Annual report pursuant to Section 13 and 15(d)

Earnings (Loss) Per Common Share (Tables)

v3.7.0.1
Earnings (Loss) Per Common Share (Tables)
 12 Months Ended
Jun. 30, 2017
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following table summarizes the components of the earnings (loss) per common share calculation (in thousands, except per share amounts):
 
 
 
Years ended
June 30,
 
 
 
2017
 
2016
 
Basic and diluted numerator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to iBio, Inc. stockholders
 
$
(14,532)
 
$
(9,764)
 
Preferred stock dividends
 
 
(90)
 
 
—
 
Net loss available to iBio, Inc. stockholders
 
$
(14,622)
 
$
(9,764)
 
 
 
 
 
 
 
 
 
Basic and diluted denominator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted-average common shares outstanding
 
 
89,112
 
 
80,973
 
 
 
 
 
 
 
 
 
Per share amount
 
$
(0.16)
 
$
(0.12)